2.6 Prophylactic, Empiric, & Therapeutic Antimicrobial Use
Key Takeaways
- Prophylactic antimicrobials prevent an infection that has not occurred, empiric therapy treats a suspected infection before the organism is known, and therapeutic (definitive) therapy is directed by culture and susceptibility results.
- Surgical antimicrobial prophylaxis should be infused within 60 minutes before incision, or within 120 minutes for vancomycin and fluoroquinolones, which require longer infusion times.
- Guidelines call for discontinuing surgical prophylaxis at the end of the procedure; continuing it beyond 24 hours does not lower surgical site infection rates and increases resistance and Clostridioides difficile risk.
- An antibiotic time-out at 48 to 72 hours is the point at which empiric therapy should be reassessed and de-escalated to definitive therapy.
- Diagnostic stewardship controls which tests are ordered and on whom, preventing colonization from being detected, reported, and then unnecessarily treated.
2.6 Prophylactic, Empiric, & Therapeutic Antimicrobial Use
Quick Answer: Prophylactic = given to a patient without infection to prevent one (surgical prophylaxis, post-exposure prophylaxis). Empiric = given for a suspected infection before the pathogen is identified, guided by syndrome, severity, and the local antibiogram. Therapeutic (definitive/directed) = given after culture and susceptibility results, narrowed to the smallest effective spectrum.
The 2025 outline places this task in Domain 1 rather than in the stewardship domain, and the reason is diagnostic: an IP who cannot tell which category a patient's antibiotics belong to cannot tell whether the antibiotics are appropriate, cannot interpret an antibiogram, and cannot recognize when a colonization result has been mistaken for infection.
The Three Categories
graph TD
A["Patient without infection"] -->|Prevent| B["PROPHYLACTIC<br/>Surgical prophylaxis, PEP,<br/>PJP prophylaxis in HIV"]
C["Suspected infection<br/>organism unknown"] -->|Cover likely pathogens| D["EMPIRIC<br/>Broad, antibiogram-guided,<br/>started after cultures drawn"]
D -->|Cultures return at 48-72h| E["THERAPEUTIC / DEFINITIVE<br/>Narrowed to the identified<br/>organism and susceptibilities"]
1. Prophylactic
Given to a patient who is not infected, to prevent infection from a defined, anticipated exposure or breach.
- Surgical antimicrobial prophylaxis — the highest-yield example
- Post-exposure prophylaxis (PEP) after a bloodborne pathogen exposure, meningococcal exposure, or rabies exposure
- Primary prophylaxis in immunocompromised hosts — for example, trimethoprim-sulfamethoxazole against Pneumocystis jirovecii
- Peri-procedural prophylaxis before invasive urologic procedures in a patient with known bacteriuria
2. Empiric
Started after cultures are drawn but before results return, when delaying therapy is dangerous. Empiric selection is driven by:
- The clinical syndrome and its likely pathogens
- Severity — septic shock justifies broader initial coverage than uncomplicated cystitis
- The local antibiogram and unit-level resistance patterns
- Patient-specific risk: prior MDRO colonization, recent antimicrobial exposure, healthcare contact, allergies, renal function
3. Therapeutic (definitive/directed)
Once the organism and its susceptibilities are known, therapy is de-escalated to the narrowest effective agent, with a defined stop date. De-escalation is one of the two highest-impact stewardship interventions, and it is why drawing cultures before the first dose matters so much: a culture-negative patient cannot be de-escalated with confidence and often stays on broad therapy for the full course.
Surgical Antimicrobial Prophylaxis in Detail
Surgical prophylaxis appears repeatedly on the exam because it is measurable, protocolized, and frequently done wrong.
| Element | Standard |
|---|---|
| Agent | Usually cefazolin; add or substitute per procedure and patient factors (e.g., add anaerobic coverage for colorectal surgery) |
| Timing | Infusion complete within 60 minutes before incision |
| Timing exception | Within 120 minutes for vancomycin and fluoroquinolones, which require prolonged infusion |
| Dose | Weight-based — under-dosing obese patients is a common failure |
| Redosing | Intraoperatively for procedures exceeding two half-lives of the agent (cefazolin roughly every 4 hours) or with major blood loss |
| Duration | Discontinue at the end of the procedure for most operations; there is no benefit beyond 24 hours |
Exam Tip: If a stem describes prophylactic antibiotics continued for three postoperative days "to be safe," the correct answer involves stopping them. Prolonged prophylaxis does not reduce surgical site infection and measurably increases C. difficile infection, acute kidney injury, and resistance.
Other prophylaxis failure modes an IP audits: administering the dose in the pre-op holding area two hours before an unexpectedly delayed incision, forgetting the intraoperative redose in a long case, and using vancomycin routinely rather than reserving it for documented beta-lactam allergy or known MRSA colonization.
The Antibiotic Time-Out
The antibiotic time-out at 48–72 hours is the structured pause where the team asks:
- Does the patient actually have an infection?
- What do the cultures show?
- Can therapy be narrowed or stopped?
- Can the route be changed from IV to oral?
- What is the stop date?
This is the operational bridge between empiric and therapeutic use, and it is a named element of CDC's Core Elements of Hospital Antibiotic Stewardship Programs.
Diagnostic Stewardship: Controlling the Upstream Trigger
The 2025 outline pairs stewardship with identification for a reason. Diagnostic stewardship means ordering the right test, on the right patient, at the right time — because a test that should never have been ordered generates a result that drives treatment that was never needed.
| Intervention | What it prevents |
|---|---|
| Reflex urine culture only when urinalysis shows pyuria | Treating asymptomatic bacteriuria |
| Hard stop on C. difficile testing for formed stool or patients on laxatives within 48 h | Converting colonization into reported infection |
| Restricting repeat blood cultures within 24 h without new clinical change | Chasing contaminants |
| Discouraging "pan-culture" order sets for isolated fever | Wide-net testing that finds colonizers |
| Avoiding surveillance cultures of wounds and tracheostomy sites without clinical indication | Treating airway and wound colonization |
Diagnostic stewardship also protects surveillance validity. Facilities that test more find more, and an SIR that rises because testing practices changed rather than because care worsened will send an IPC program chasing the wrong problem entirely.
A patient is scheduled for a hip arthroplasty at 08:00 and requires vancomycin prophylaxis due to documented beta-lactam allergy and known MRSA colonization. When should the infusion be completed?
A patient with septic shock has blood cultures drawn and is started on vancomycin plus piperacillin-tazobactam. Forty-eight hours later, cultures grow methicillin-susceptible Staphylococcus aureus. What category of therapy should now be used, and what action does stewardship require?
A surgeon routinely continues cefazolin for 72 hours after uncomplicated elective procedures. What is the correct infection prevention response?
A facility implements an electronic rule that cancels Clostridioides difficile test orders when the stool specimen is formed or the patient received a laxative in the previous 48 hours. What is this intervention called, and what does it primarily prevent?